<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30231078</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Sep</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Crystal structure of a soluble fragment of poliovirus 2CATPase.</ArticleTitle><Pagination><StartPage>e1007304</StartPage><MedlinePgn>e1007304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1007304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1007304</ELocationID><Abstract><AbstractText>Poliovirus (PV) 2CATPase is the most studied 2C protein in the Picornaviridae family. It is involved in RNA replication, encapsidation and uncoating and many inhibitors have been found that target PV 2CATPase. Despite numerous investigations to characterize its functions, a high-resolution structure of PV 2C has not yet been determined. We report here the crystal structure of a soluble fragment of PV 2CATPase to 2.55&#xc5;, containing an ATPase domain, a zinc finger and a C-terminal helical domain but missing the N-terminal domain. The ATPase domain shares the common structural features with EV71 2C and other Superfamily 3 helicases. The C-terminal cysteine-rich motif folds into a CCCC type zinc finger in which four cysteine ligands and several auxiliary residues assist in zinc binding. By comparing with the known zinc finger fold groups, we found the zinc finger of 2C proteins belong to a new fold group, which we denote the "Enterovirus 2C-like" group. The C-terminus of PV 2CATPase forms an amphipathic helix that occupies a hydrophobic pocket located on an adjacent PV 2CATPase in the crystal lattice. The C-terminus mediated PV 2C-2C interaction promotes self-oligomerization, most likely hexamerization, which is fundamental to the ATPase activity of 2C. The zinc finger is the most structurally diverse feature in 2C proteins. Available structural and virological data suggest that the zinc finger of 2C might confer the specificity of interaction with other proteins. We built a hexameric ring model of PV 2CATPase and visualized the previously identified functional motifs and drug-resistant sites, thus providing a structure framework for antiviral drug development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Hongxin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>MOH key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MOH key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>MOH key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>MOH key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6329-3582</Identifier><AffiliationInfo><Affiliation>MOH key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020836" MajorTopicYN="N">Protein Structure, Quaternary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055672" MajorTopicYN="N">Static Electricity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30231078</ArticleId><ArticleId IdType="pmc">PMC6166989</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1007304</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-18-00779</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Couderc T, Christodoulou C, Kopecka H, Marsden S, Taffs LF, et al. (1989) Molecular pathogenesis of neural lesions induced by poliovirus type 1. J Gen Virol 70 (Pt 11): 2907&#x2013;2918.</Citation><ArticleIdList><ArticleId IdType="pubmed">2555432</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanelli P, Buttinelli G, Rezza G (2016) Poliomyelitis: residual hurdles to global eradication. Commentary. Ann Ist Super Sanita 52: 469&#x2013;471. 10.4415/ANN_16_04_01</Citation><ArticleIdList><ArticleId IdType="doi">10.4415/ANN_16_04_01</ArticleId><ArticleId IdType="pubmed">27999213</ArticleId></ArticleIdList></Reference><Reference><Citation>Collett MS, Neyts J, Modlin JF (2008) A case for developing antiviral drugs against polio. Antiviral Res 79: 179&#x2013;187. 10.1016/j.antiviral.2008.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2008.04.002</ArticleId><ArticleId IdType="pubmed">18513807</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin J (2006) Infectious diseases. Report concludes polio drugs are needed&#x2014;after disease is eradicated. Science 311: 1539.</Citation><ArticleIdList><ArticleId IdType="pubmed">16543427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, et al. (2017) ICTV Virus Taxonomy Profile: Picornaviridae. J Gen Virol 98: 2421&#x2013;2422. 10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber HK (1971) Flexner and Noguchi's globoid red herrings: a footnote to the history of poliomyelitis. J Infect Dis 124: 231&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">4331000</ArticleId></ArticleIdList></Reference><Reference><Citation>Norder H, De Palma AM, Selisko B, Costenaro L, Papageorgiou N, et al. (2011) Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res 89: 204&#x2013;218. 10.1016/j.antiviral.2010.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.12.007</ArticleId><ArticleId IdType="pubmed">21236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Lyoo H, van der Schaar HM, Strating JR, van Kuppeveld FJ (2017) Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr Opin Virol 24: 1&#x2013;8. 10.1016/j.coviro.2017.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus SE, Diamond DC, Emini EA, Wimmer E (1986) Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol 57: 638&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC252779</ArticleId><ArticleId IdType="pubmed">3003395</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolskaya EA, Romanova LI, Kolesnikova MS, Gmyl AP, Gorbalenya AE, et al. (1994) Genetic studies on the poliovirus 2C protein, an NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J Mol Biol 236: 1310&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">8126722</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M, Hadaschik D, Zimmermann H, Eggers HJ, Nelsen-Salz B (2000) The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J Gen Virol 81: 895&#x2013;901. 10.1099/0022-1317-81-4-895</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-4-895</ArticleId><ArticleId IdType="pubmed">10725414</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma AM, Heggermont W, Lanke K, Coutard B, Bergmann M, et al. (2008) The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C. J Virol 82: 4720&#x2013;4730. 10.1128/JVI.01338-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01338-07</ArticleId><ArticleId IdType="pmc">PMC2346740</ArticleId><ArticleId IdType="pubmed">18337578</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L, Wolthers KC, van Kuppeveld FJ (2015) Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses 7: 4529&#x2013;4562. 10.3390/v7082832</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Agoh M, Agoh Y, Yoshida H, Yoshii K, et al. (2000) Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. J Virol 74: 4146&#x2013;4154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111929</ArticleId><ArticleId IdType="pubmed">10756027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulferts R, de Boer SM, van der Linden L, Bauer L, Lyoo HR, et al. (2016) Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C. Antimicrob Agents Chemother 60: 2627&#x2013;2638. 10.1128/AAC.02182-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02182-15</ArticleId><ArticleId IdType="pmc">PMC4862474</ArticleId><ArticleId IdType="pubmed">26856848</ArticleId></ArticleIdList></Reference><Reference><Citation>Verlinden Y, Cuconati A, Wimmer E, Rombaut B (2000) The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system. Antiviral Res 48: 61&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">11080541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J, Quinn KK, Kye S, Cooper P, Damoiseaux R, et al. (2012) Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother 56: 4838&#x2013;4844. 10.1128/AAC.00983-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00983-12</ArticleId><ArticleId IdType="pmc">PMC3421851</ArticleId><ArticleId IdType="pubmed">22751539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulferts R, van der Linden L, Thibaut HJ, Lanke KH, Leyssen P, et al. (2013) Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C. Antimicrob Agents Chemother 57: 1952&#x2013;1956. 10.1128/AAC.02084-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02084-12</ArticleId><ArticleId IdType="pmc">PMC3623316</ArticleId><ArticleId IdType="pubmed">23335743</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Saleh MC, Gitlin L, Beske O, Andino R (2004) The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein. J Virol 78: 3378&#x2013;3386. 10.1128/JVI.78.7.3378-3386.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.7.3378-3386.2004</ArticleId><ArticleId IdType="pmc">PMC371039</ArticleId><ArticleId IdType="pubmed">15016860</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, Weidman MK, Echeverri A, Kundu P, Dasgupta A (2004) Regulation of poliovirus 3C protease by the 2C polypeptide. J Virol 78: 9243&#x2013;9256. 10.1128/JVI.78.17.9243-9256.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.17.9243-9256.2004</ArticleId><ArticleId IdType="pmc">PMC506913</ArticleId><ArticleId IdType="pubmed">15308719</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Qin B, Wojdyla JA, Wang B, et al. (2017) Crystal structure of 2C helicase from enterovirus 71. Sci Adv 3: e1602573 10.1126/sciadv.1602573</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1602573</ArticleId><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JP, Baltimore D (1990) An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol 64: 1102&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC249223</ArticleId><ArticleId IdType="pubmed">2154595</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA, Nair V, Hansen BT, Hoyt FH, Fischer ER, et al. (2012) Complex dynamic development of poliovirus membranous replication complexes. J Virol 86: 302&#x2013;312. 10.1128/JVI.05937-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05937-11</ArticleId><ArticleId IdType="pmc">PMC3255921</ArticleId><ArticleId IdType="pubmed">22072780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E (1994) Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202: 129&#x2013;145. 10.1006/viro.1994.1329</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1329</ArticleId><ArticleId IdType="pubmed">8009827</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldabe R, Carrasco L (1995) Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun 206: 64&#x2013;76. 10.1006/bbrc.1995.1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1995.1010</ArticleId><ArticleId IdType="pubmed">7818552</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina NL, Kean KM, Gorbalenya AE, Agol VI, Girard M (1992) Analysis of the functional significance of amino acid residues in the putative NTP-binding pattern of the poliovirus 2C protein. J Gen Virol 73 (Pt 8): 1977&#x2013;1986.</Citation><ArticleIdList><ArticleId IdType="pubmed">1322957</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E (1997) Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol 71: 8962&#x2013;8972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230196</ArticleId><ArticleId IdType="pubmed">9371552</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton DJ, Flanegan JB (1997) Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol 71: 8482&#x2013;8489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192311</ArticleId><ArticleId IdType="pubmed">9343205</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JP, Baltimore D (1988) Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J Virol 62: 4016&#x2013;4021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC253830</ArticleId><ArticleId IdType="pubmed">2845120</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Molla A, Wimmer E (1994) Studies of a putative amphipathic helix in the N-terminus of poliovirus protein 2C. Virology 199: 188&#x2013;199. 10.1006/viro.1994.1111</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1111</ArticleId><ArticleId IdType="pubmed">8116242</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance LM, Moscufo N, Chow M, Heinz BA (1997) Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71: 8759&#x2013;8765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192341</ArticleId><ArticleId IdType="pubmed">9343235</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, et al. (2010) Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6: e1001066 10.1371/journal.ppat.1001066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E (2014) Picornavirus morphogenesis. Microbiol Mol Biol Rev 78: 418&#x2013;437. 10.1128/MMBR.00012-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00012-14</ArticleId><ArticleId IdType="pmc">PMC4187686</ArticleId><ArticleId IdType="pubmed">25184560</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Jiang P, Sand C, Paul AV, Wimmer E (2012) Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis. J Virol 86: 9964&#x2013;9975. 10.1128/JVI.00914-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00914-12</ArticleId><ArticleId IdType="pmc">PMC3446611</ArticleId><ArticleId IdType="pubmed">22761387</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverri A, Banerjee R, Dasgupta A (1998) Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res 54: 217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">9696129</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E (2009) Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J Biol Chem 284: 22012&#x2013;22021. 10.1074/jbc.M109.031807</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.031807</ArticleId><ArticleId IdType="pmc">PMC2755925</ArticleId><ArticleId IdType="pubmed">19520852</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez PL, Carrasco L (1995) Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem 270: 10105&#x2013;10112.</Citation><ArticleIdList><ArticleId IdType="pubmed">7730315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuconati A, Xiang W, Lahser F, Pfister T, Wimmer E (1998) A protein linkage map of the P2 nonstructural proteins of poliovirus. J Virol 72: 1297&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124608</ArticleId><ArticleId IdType="pubmed">9445030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Liu Y, Wimmer E, Paul AV (2007) Complete protein linkage map between the P2 and P3 non-structural proteins of poliovirus. J Gen Virol 88: 2259&#x2013;2267. 10.1099/vir.0.82795-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82795-0</ArticleId><ArticleId IdType="pubmed">17622630</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL, et al. (2007) Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem 282: 5888&#x2013;5898. 10.1074/jbc.M611145200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611145200</ArticleId><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzayan C, Wimmer E (1994) Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 199: 176&#x2013;187. 10.1006/viro.1994.1110</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1110</ArticleId><ArticleId IdType="pubmed">8116241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister T, Wimmer E (1999) Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem 274: 6992&#x2013;7001.</Citation><ArticleIdList><ArticleId IdType="pubmed">10066753</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister T, Jones KW, Wimmer E (2000) A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro. J Virol 74: 334&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111544</ArticleId><ArticleId IdType="pubmed">10590122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MW, Richards OC, Dmitrieva TM, Agol V, Ehrenfeld E (1993) RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol 67: 3010&#x2013;3018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237637</ArticleId><ArticleId IdType="pubmed">8388485</ArticleId></ArticleIdList></Reference><Reference><Citation>Parthasarathy G, Cummings R, Becker JW, Soisson SM (2008) Surface-entropy reduction approaches to manipulate crystal forms of beta-ketoacyl acyl carrier protein synthase II from Streptococcus pneumoniae. Acta Crystallogr D Biol Crystallogr 64: 141&#x2013;148. 10.1107/S090744490705559X</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S090744490705559X</ArticleId><ArticleId IdType="pubmed">18219113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai K, Nagata N (2012) Metal-ligand interactions: an analysis of zinc binding groups using the Protein Data Bank. Eur J Med Chem 51: 271&#x2013;276. 10.1016/j.ejmech.2012.02.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2012.02.028</ArticleId><ArticleId IdType="pubmed">22405284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, et al. (2010) Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J Biol Chem 285: 24347&#x2013;24359. 10.1074/jbc.M110.129940</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.129940</ArticleId><ArticleId IdType="pmc">PMC2915670</ArticleId><ArticleId IdType="pubmed">20507978</ArticleId></ArticleIdList></Reference><Reference><Citation>Springer CL, Huntoon HP, Peersen OB (2013) Polyprotein context regulates the activity of poliovirus 2CATPase bound to bilayer nanodiscs. J Virol 87: 5994&#x2013;6004. 10.1128/JVI.03491-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03491-12</ArticleId><ArticleId IdType="pmc">PMC3648184</ArticleId><ArticleId IdType="pubmed">23514879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ma HC, Wimmer E, Jiang P, Paul AV (2014) A C-terminal, cysteine-rich site in poliovirus 2C(ATPase) is required for morphogenesis. J Gen Virol 95: 1255&#x2013;1265. 10.1099/vir.0.062497-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.062497-0</ArticleId><ArticleId IdType="pmc">PMC4027037</ArticleId><ArticleId IdType="pubmed">24558221</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna SS, Majumdar I, Grishin NV (2003) Structural classification of zinc fingers: survey and summary. Nucleic Acids Res 31: 532&#x2013;550. 10.1093/nar/gkg161</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg161</ArticleId><ArticleId IdType="pmc">PMC140525</ArticleId><ArticleId IdType="pubmed">12527760</ArticleId></ArticleIdList></Reference><Reference><Citation>Asare E, Mugavero J, Jiang P, Wimmer E, Paul AV (2016) A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating. J Virol 90: 6174&#x2013;6186. 10.1128/JVI.02877-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02877-15</ArticleId><ArticleId IdType="pmc">PMC4936127</ArticleId><ArticleId IdType="pubmed">27076638</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486&#x2013;501. 10.1107/S0907444910007493</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213&#x2013;221. 10.1107/S0907444909052925</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez PL, Carrasco L (1993) Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem 268: 8105&#x2013;8110.</Citation><ArticleIdList><ArticleId IdType="pubmed">8385138</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragon-Sanchez J, Quintana-Marrero Y, Aragon-Hernandez C, Hernandez-Herero MJ (2017) ImageJ: A Free, Easy, and Reliable Method to Measure Leg Ulcers Using Digital Pictures. Int J Low Extrem Wounds 16: 269&#x2013;273. 10.1177/1534734617744951</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1534734617744951</ArticleId><ArticleId IdType="pubmed">29251541</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>